A randomized controlled trial on patients with or without adjuvant autologous cytokine- induced killer cells after curative resection for hepatocellular carcinoma

2022-01-10T10:24:26+00:00January 10th, 2022|

A randomized controlled trial on patients with or without adjuvant autologous cytokine- induced killer cells after curative resection for hepatocellular carcinoma Overall Survival CONTACT US Summary [...]

In situ delivery of allogeneic natural killer cell (NK) combined with Cetuximab in liver metastases of gastrointestinal carcinoma: A phase I clinical trial

2021-12-23T09:01:44+00:00December 23rd, 2021|

In situ delivery of allogeneic natural killer cell (NK) combined with Cetuximab in liver metastases of gastrointestinal carcinoma: A phase I clinical trial Clinical Activity CONTACT US Summary In [...]

Allogenic Natural Killer Cell Immunotherapy Combined with Irreversible Electroporation for Stage IV Hepatocellular Carcinoma: Survival Outcome

2021-12-23T09:06:01+00:00December 23rd, 2021|

Allogenic Natural Killer Cell Immunotherapy Combined with Irreversible Electroporation for Stage IV Hepatocellular Carcinoma: Survival Outcome MRI CONTACT US Summary The study evaluates the clinical effectiveness of irreversible electroporation [...]

The combination of Dendritic cells-cytotoxic T lymphocytes/cytokine-induced killer (DC-CTL/CIK) therapy exerts immune and clinical responses in patients with malignant tumors

2021-12-16T07:30:27+00:00December 16th, 2021|

The combination of Dendritic cells-cytotoxic T lymphocytes/cytokine-induced killer (DC-CTL/CIK) therapy exerts immune and clinical responses in patients with malignant tumors Detection of CIKs,CTLs and intracellular IFN-Y in T cells by flow cytometry [...]

Go to Top